Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · October 10, 2023

12-Month vs 3-Month Edoxaban in Patients With Cancer and Isolated Distal Deep Vein Thrombosis



Additional Info

Disclosure statements are available on the authors' profiles:

Edoxaban for 12 Months Versus 3 Months in Cancer Patients With Isolated Distal Deep Vein Thrombosis (ONCO DVT study): An Open-label, Multicenter, Randomized Clinical Trial
Circulation 2023 Aug 28;[EPub Ahead of Print], Y Yamashita, T Morimoto, N Muraoka, T Oyakawa, M Umetsu, D Akamatsu, Y Nishimoto, Y Sato, T Takada, K Jujo, Y Minami, Y Ogihara, K Dohi, M Fujita, T Nishikawa, N Ikeda, G Hashimoto, K Otsui, K Mori, D Sueta, Y Tsubata, M Shoji, A Shikama, Y Hosoi, Y Tanabe, R Chatani, K Tsukahara, N Nakanishi, K Kim, S Ikeda, M Mo, Y Yoshikawa, T Kimura

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading